Immunotherapy can be used to treat autoimmune diseases. One of the methods is T cell vaccination, which is used to treat multiple sclerosis and rheumatoid arthritis. Usually, immune cells that recognize their own tissues do not cause adverse effects due to the fact that they are removed after the recognition. However, when the immune regulation is impaired, these immune cells are not destroyed and react to their own tissues as to alien substances of the body. That is the reason why the destruction of the own tissue starts and develops the autoimmune disease.

T cells immunotherapy is based on the fact that an autoimmune reaction in the body is caused by its own immune cells against its own tissue. The method allows to control this process and prevent it at the activation stage. Disease-specific T and B cells are collected from the patient’s blood (preferably during the course of the active autoimmune response). These cells are multiplied, inactivated and used for T cell vaccine is preparation in the laboratory. The vaccine is injected intramuscularly according to the appropriate treatment plan. The inactivated disease-specific cells in the vaccine are capable to initiate an immune response against the disease-causing cells in the patient’s body and get them inactivated. Most importantly, the inactivation occurs during the initial stages of the autoimmune response hence preventing processes that lead to further consequences of the disease.

This therapy is mostly effective for patients with remitting forms of multiple sclerosis and all forms of rheumatoid arthritis.

If you are interested in this treatment, do not hesitate to contact us. At the Clinic, you will be provided with full details of the possible applications of the immunotherapy.

For more information, please register for the appointment of an oncology chemotherapist and immunologist. Contact us on +370 52 77 33 57 or by email: